Skip to content

Clinical trials

Completed Lung Neoplasms trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Completed Country / region: Singapore Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20063
20071
20082
20092
20101
20112
20122
20133
20141
20152
20162
20171
20182
20191
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Singapore General Hospital3
Boehringer Ingelheim2
Bristol-Myers Squibb2
AVEO Pharmaceuticals, Inc.1
Alpha Biopharma (Jiangsu) Co., Ltd.1
Amgen1
Arcus Biosciences, Inc.1
Ariad Pharmaceuticals1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms32
Carcinoma, Non-Small-Cell Lung23
Adenocarcinoma of Lung8
Carcinoma4
Neoplasms4
Adenocarcinoma3
Respiratory Tract Diseases3
Colonic Neoplasms2
Colorectal Neoplasms2
Intestinal Neoplasms2

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.